# Coeur Mining, Inc.: financial statements, quarterly

CDE · NYSE · CIK 215466 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cde.md) · [Financials](/companies/cde/financials.md) · [Filings](/companies/cde/filings.md) · [Insiders](/companies/cde/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cde/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [195](/filings/0000215466-24-000122.md) | [262 d](/filings/0000215466-26-000004.md) | [213](/filings/0000215466-25-000075.md) | [222](/filings/0000215466-25-000123.md) | [313](/filings/0000215466-25-000137.md) | [305 d](/filings/0000215466-26-000004.md) | [360](/filings/0000215466-26-000019.md) | [481](/filings/0000215466-26-000036.md) | [555](/filings/0000215466-25-000137.md) | [675 d](/filings/0000215466-26-000004.md) | [856](/filings/0000215466-26-000019.md) | [1,086](/filings/0000215466-26-000036.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | [(3.4)](/filings/0000215466-25-000075.md) | [16.7](/filings/0000215466-25-000123.md) | [84.4](/filings/0000215466-25-000137.md) | [66.5 d](/filings/0000215466-26-000004.md) | [62.2](/filings/0000215466-26-000019.md) | [140](/filings/0000215466-26-000036.md) | [177](/filings/0000215466-25-000137.md) | [328 d](/filings/0000215466-26-000004.md) | [349](/filings/0000215466-26-000019.md) | [217](/filings/0000215466-26-000036.md) |
| Interest expense | $m | [7.4](/filings/0000215466-24-000122.md) | [7.4 d](/filings/0000215466-24-000008.md) | [12.9](/filings/0000215466-24-000077.md) | [13.2](/filings/0000215466-24-000095.md) | [13.3](/filings/0000215466-24-000122.md) | [11.9 d](/filings/0000215466-25-000069.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [6.1](/filings/0000215466-24-000122.md) | [8.5 d](/filings/0000215466-26-000004.md) | [16.0](/filings/0000215466-25-000075.md) | [7.2](/filings/0000215466-25-000123.md) | [25.8](/filings/0000215466-25-000137.md) | [18.4 d](/filings/0000215466-26-000004.md) | [18.4](/filings/0000215466-26-000019.md) | [62.6](/filings/0000215466-26-000036.md) | [(96.9)](/filings/0000215466-25-000137.md) | [113 d](/filings/0000215466-26-000004.md) | [102](/filings/0000215466-26-000019.md) | [93.2](/filings/0000215466-26-000036.md) |
| Net income | $m | [(21.1)](/filings/0000215466-24-000122.md) | [(25.5) d](/filings/0000215466-26-000004.md) | [(29.1)](/filings/0000215466-25-000137.md) | [1.4](/filings/0000215466-25-000137.md) | [48.7](/filings/0000215466-25-000137.md) | [37.9 d](/filings/0000215466-26-000004.md) | [33.4](/filings/0000215466-26-000036.md) | [70.7](/filings/0000215466-26-000036.md) | [267](/filings/0000215466-25-000137.md) | [215 d](/filings/0000215466-26-000004.md) | [247](/filings/0000215466-26-000036.md) | [122](/filings/0000215466-26-000036.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0000215466-24-000122.md) | not reported | [(0.08)](/filings/0000215466-25-000075.md) | [0.00](/filings/0000215466-25-000123.md) | [0.12](/filings/0000215466-25-000137.md) | not reported | [0.06](/filings/0000215466-26-000019.md) | [0.11](/filings/0000215466-26-000036.md) | [0.41](/filings/0000215466-25-000137.md) | not reported | [0.35](/filings/0000215466-26-000019.md) | [0.12](/filings/0000215466-26-000036.md) |
| Basic EPS | $ per share | [(0.06)](/filings/0000215466-24-000122.md) | not reported | [(0.08)](/filings/0000215466-25-000075.md) | [0.00](/filings/0000215466-25-000123.md) | [0.12](/filings/0000215466-25-000137.md) | not reported | [0.06](/filings/0000215466-26-000019.md) | [0.11](/filings/0000215466-26-000036.md) | [0.42](/filings/0000215466-25-000137.md) | not reported | [0.36](/filings/0000215466-26-000019.md) | [0.12](/filings/0000215466-26-000036.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000215466-24-000122.md) | [0.1](/filings/0000215466-25-000069.md) | [0.1](/filings/0000215466-25-000075.md) | [0.1](/filings/0000215466-25-000123.md) | [0.1](/filings/0000215466-25-000137.md) | [0.1](/filings/0000215466-26-000004.md) | [0.1](/filings/0000215466-26-000019.md) | [0.1](/filings/0000215466-26-000036.md) | [0.3](/filings/0000215466-25-000137.md) | [0.6](/filings/0000215466-26-000036.md) | [0.8](/filings/0000215466-26-000019.md) | [1.1](/filings/0000215466-26-000036.md) |
| Current assets | $bn | [0.3](/filings/0000215466-23-000146.md) | [0.3](/filings/0000215466-25-000069.md) | [0.3](/filings/0000215466-24-000077.md) | [0.3](/filings/0000215466-24-000095.md) | [0.3](/filings/0000215466-24-000122.md) | [0.3](/filings/0000215466-26-000004.md) | [0.5](/filings/0000215466-25-000075.md) | [0.5](/filings/0000215466-25-000123.md) | [0.7](/filings/0000215466-25-000137.md) | [1.0](/filings/0000215466-26-000036.md) | [1.7](/filings/0000215466-26-000019.md) | [1.8](/filings/0000215466-26-000036.md) |
| Total assets | $bn | [2.1](/filings/0000215466-23-000146.md) | [2.1](/filings/0000215466-25-000069.md) | [2.1](/filings/0000215466-24-000077.md) | [2.1](/filings/0000215466-24-000095.md) | [2.2](/filings/0000215466-24-000122.md) | [2.3](/filings/0000215466-26-000004.md) | [4.1](/filings/0000215466-25-000075.md) | [4.2](/filings/0000215466-25-000123.md) | [4.5](/filings/0000215466-25-000137.md) | [4.7](/filings/0000215466-26-000036.md) | [15.3](/filings/0000215466-26-000019.md) | [15.2](/filings/0000215466-26-000036.md) |
| Current liabilities | $bn | [0.3](/filings/0000215466-23-000146.md) | [0.3](/filings/0000215466-25-000069.md) | [0.3](/filings/0000215466-24-000077.md) | [0.3](/filings/0000215466-24-000095.md) | [0.3](/filings/0000215466-24-000122.md) | [0.3](/filings/0000215466-26-000004.md) | [0.3](/filings/0000215466-25-000075.md) | [0.3](/filings/0000215466-25-000123.md) | [0.3](/filings/0000215466-25-000137.md) | [0.4](/filings/0000215466-26-000036.md) | [0.5](/filings/0000215466-26-000019.md) | [0.5](/filings/0000215466-26-000036.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.0](/filings/0000215466-23-000146.md) | [0.0](/filings/0000215466-25-000069.md) | [0.0](/filings/0000215466-24-000077.md) | [0.0](/filings/0000215466-24-000095.md) | [0.0](/filings/0000215466-24-000122.md) | [0.0](/filings/0000215466-26-000004.md) | [0.0](/filings/0000215466-25-000075.md) | [0.0](/filings/0000215466-25-000123.md) | [0.0](/filings/0000215466-25-000137.md) | [0.0](/filings/0000215466-26-000036.md) | [0.0](/filings/0000215466-26-000019.md) | [0.0](/filings/0000215466-26-000036.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.0](/filings/0000215466-24-000122.md) | [1.0](/filings/0000215466-26-000004.md) | [1.0](/filings/0000215466-25-000137.md) | [1.0](/filings/0000215466-25-000137.md) | [1.1](/filings/0000215466-25-000137.md) | [1.1](/filings/0000215466-26-000036.md) | [2.7](/filings/0000215466-26-000036.md) | [2.8](/filings/0000215466-26-000036.md) | [3.1](/filings/0000215466-25-000137.md) | [3.3](/filings/0000215466-26-000036.md) | [10.4](/filings/0000215466-26-000036.md) | [10.4](/filings/0000215466-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.4)](/filings/0000215466-24-000122.md) | [65.3 d](/filings/0000215466-26-000004.md) | [(15.9)](/filings/0000215466-25-000075.md) | [15.2](/filings/0000215466-25-000123.md) | [111](/filings/0000215466-25-000137.md) | [63.8 d](/filings/0000215466-26-000004.md) | [67.6](/filings/0000215466-26-000019.md) | [207](/filings/0000215466-26-000036.md) | [238](/filings/0000215466-25-000137.md) | [375 d](/filings/0000215466-26-000004.md) | [341](/filings/0000215466-26-000019.md) | [513](/filings/0000215466-26-000036.md) |
| Capital expenditure | $m | [112](/filings/0000215466-24-000122.md) | [92.7 d](/filings/0000215466-26-000004.md) | [42.1](/filings/0000215466-25-000075.md) | [51.4](/filings/0000215466-25-000123.md) | [42.0](/filings/0000215466-25-000137.md) | [47.7 d](/filings/0000215466-26-000004.md) | [50.0](/filings/0000215466-26-000019.md) | [60.8](/filings/0000215466-26-000036.md) | [49.0](/filings/0000215466-25-000137.md) | [61.3 d](/filings/0000215466-26-000004.md) | [74.1](/filings/0000215466-26-000019.md) | [126](/filings/0000215466-26-000036.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000215466-26-000036.md) | not reported | not reported | not reported | [20.6](/filings/0000215466-26-000036.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [278](/filings/0000215466-23-000146.md) | [301](/filings/0000215466-24-000077.md) | [333](/filings/0000215466-24-000095.md) | [357](/filings/0000215466-24-000122.md) | [385](/filings/0000215466-25-000075.md) | [400](/filings/0000215466-25-000123.md) | [401](/filings/0000215466-25-000137.md) | [521](/filings/0000215466-26-000019.md) | [643](/filings/0000215466-26-000036.md) | [645](/filings/0000215466-25-000137.md) | [699](/filings/0000215466-26-000019.md) | [1,034](/filings/0000215466-26-000036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,027,934,998 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0000215466-26-000036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.